Matches in Wikidata for { <http://www.wikidata.org/entity/Q65383310> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q65383310 description "clinical trial" @default.
- Q65383310 description "ensayu clínicu" @default.
- Q65383310 description "klinisch onderzoek" @default.
- Q65383310 description "клінічне випробування" @default.
- Q65383310 name "Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults" @default.
- Q65383310 name "Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults" @default.
- Q65383310 type Item @default.
- Q65383310 label "Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults" @default.
- Q65383310 label "Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults" @default.
- Q65383310 prefLabel "Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults" @default.
- Q65383310 prefLabel "Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults" @default.
- Q65383310 P1132 Q65383310-CE10BEEB-1163-4BA4-B4E6-F7CEB4F04BA5 @default.
- Q65383310 P1476 Q65383310-B515E6C1-6B8C-4073-8FF4-6A09E1E1C52C @default.
- Q65383310 P17 Q65383310-86870071-8BD4-4778-9539-2D0AF7567BF3 @default.
- Q65383310 P2899 Q65383310-FBCD194E-4683-46F2-92C1-EA464A495CAC @default.
- Q65383310 P3098 Q65383310-AC667DD4-06DA-407C-B4D6-D1B01540A1A1 @default.
- Q65383310 P31 Q65383310-501EFC81-408F-403C-A2E2-2A2CA66D21D8 @default.
- Q65383310 P4135 Q65383310-8F6387E0-83F1-44D1-8E4E-125FFA70AEEE @default.
- Q65383310 P580 Q65383310-84A33EDA-7D58-401D-81FA-E6048EC382E2 @default.
- Q65383310 P582 Q65383310-3DE5CB2D-3324-42D6-A714-9EDAA94EA0A2 @default.
- Q65383310 P6099 Q65383310-F35BFAF1-61E7-489A-8419-1A5435C0682B @default.
- Q65383310 P8363 Q65383310-EE52C7C0-438E-4D70-8AB0-4271645A03FD @default.
- Q65383310 P921 Q65383310-4AE578B2-E2DF-4022-87CC-177DBC1BBD52 @default.
- Q65383310 P1132 "+17" @default.
- Q65383310 P1476 "A Phase 1B Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Adenoviral Serotype 35 (rAd35) and Serotype 5 (rAd5) HIV-1 Vaccines When Given in Heterologous Prime-Boost Regimens or as a Boost to a Recombinant DNA Vaccine in Healthy, HIV-1-Uninfected Adult Participants With Pre-Existing Immunity to Adenovirus Serotype 5 Infection" @default.
- Q65383310 P17 Q30 @default.
- Q65383310 P2899 "+18" @default.
- Q65383310 P3098 "NCT00472719" @default.
- Q65383310 P31 Q30612 @default.
- Q65383310 P4135 "+50" @default.
- Q65383310 P580 "2007-08-01T00:00:00Z" @default.
- Q65383310 P582 "2008-07-01T00:00:00Z" @default.
- Q65383310 P6099 Q5452194 @default.
- Q65383310 P8363 Q78089383 @default.
- Q65383310 P921 Q837054 @default.